|
C14ORF126 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.89819999999852E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.7572999995491E-07 |
| Normal-vs-Stage2 |
5.060700E-03 |
| Normal-vs-Stage3 |
1.074380E-02 |
| Normal-vs-Stage4 |
5.637200E-01 |
| Stage1-vs-Stage2 |
4.473600E-01 |
| Stage1-vs-Stage3 |
1.812840E-01 |
| Stage1-vs-Stage4 |
5.461600E-02 |
| Stage2-vs-Stage3 |
7.181800E-01 |
| Stage2-vs-Stage4 |
2.412800E-01 |
| Stage3-vs-Stage4 |
3.335800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.27379999999666E-05 |
| Normal-vs-AfricanAmerican |
6.640600E-04 |
| Normal-vs-Asian |
1.466630E-01 |
| Caucasian-vs-AfricanAmerican |
5.753400E-01 |
| Caucasian-vs-Asian |
5.528200E-01 |
| AfricanAmerican-vs-Asian |
7.481200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.94869999528657E-08 |
| Normal-vs-Female |
1.054840E-01 |
| Male-vs-Female |
1.804420E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.763500E-04 |
| Normal-vs-Extreme_Weight |
2.19339999996127E-06 |
| Normal-vs-Obese |
1.203000E-03 |
| Normal-vs-Extreme_Obese |
5.632100E-04 |
| Normal_Weight-vs-Extreme_Weight |
3.964200E-01 |
| Normal_Weight-vs-Obese |
5.665600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.047600E-01 |
| Extreme_Weight-vs-Obese |
9.415700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.817000E-01 |
| Obese-vs-Extreme_Obese |
2.896800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.797800E-01 |
| Normal-vs-Age(41-60Yrs) |
5.195700E-04 |
| Normal-vs-Age(61-80Yrs) |
1.89760000046668E-07 |
| Normal-vs-Age(81-100Yrs) |
1.122140E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.304600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.014300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.046600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.062030E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.215800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.689000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.49349999981163E-07 |
| Normal-VS-Type2 PRCC |
1.79983999999411E-05 |
| Normal-VS-KIRP CIMP |
7.294200E-01 |
| Normal-VS-Unclassified PRCC |
2.136400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.581200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.565700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.279170E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.562400E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.547620E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.399800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.38330000001952E-06 |
| Normal-vs-N1 |
7.121000E-01 |
| Normal-vs-N2 |
1.188780E-04 |
| N0-vs-N1 |
8.798900E-04 |
| N0-vs-N2 |
9.651800E-02 |
| N1-vs-N2 |
9.998400E-03 |
|
|
